Skip to main content
SpringerLink
Log in

Endometriumkarzinom

Immuntherapie in Kombination mit der Chemotherapie

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Miller DS et al. J Clin Oncol. 2020;38(33):3841-50

  2. Hiller GGR et al. Onkologie. 2023; 29(5):406-16

  3. Oaknin A et al. JAMA Oncol. 2020;6(11):1766-72

  4. Cercek A et al. N Engl J Med. 2022;386(25):2363-76

  5. Eskander RN et al. N Engl J Med. 2023;388(23):2159-70

  6. Mirza MR et al. N Engl J Med. 2023;388(23):2145-58

  7. O'Malley DM et al. J Clin Oncol. 2022;40(7):752-61

  8. Pauly N, Ataseven B. Onkologie.2023;29(5):435-43

  9. Lüftner D. Onkologie.2023;29(5):431-34

  10. Oaknin A et al. J Immunother Cancer. 2022;10(1):e003777

  11. Calo CA et al. Gynecol Oncol Rep. 2023;46:101171

Download references

Author information

Authors and Affiliations

  1. Facharzt für Onkologie, Lena-Christ-Str. 17, 82152, Planegg, Deutschland

    Andreas Schalhorn

Authors
  1. Andreas Schalhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schalhorn, A. Immuntherapie in Kombination mit der Chemotherapie. InFo Hämatol Onkol 26, 26–27 (2023). https://doi.org/10.1007/s15004-023-0006-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-023-0006-y

Search

Navigation